|
Malignant neoplasm of prostate
|
0.500 |
Biomarker
|
disease |
BEFREE |
Prostate cancer-associated ncRNA transcripts 1 (PCAT-1), a lncRNA, has been recently revealed involving in human prostate cancer progression.
|
23640607 |
2013 |
|
Malignant neoplasm of prostate
|
0.500 |
Biomarker
|
disease |
BEFREE |
Prostate cancer-associated ncRNA transcript 1 (PCAT-1) is one of the lncRNAs involved in cell apoptosis and proliferation of prostate cancer.
|
25731728 |
2015 |
|
Malignant neoplasm of prostate
|
0.500 |
Biomarker
|
disease |
BEFREE |
Prostate cancer-associated transcript 1 (PCAT-1) is a novel lncRNA that promotes cell proliferation in prostate cancer, however, the effect of PCAT‑1 in hepatocellular carcinoma (HCC) remains to be elucidated.
|
27035680 |
2016 |
|
Malignant neoplasm of prostate
|
0.500 |
Biomarker
|
disease |
BEFREE |
Prostate cancer-associated transcript1 (PCAT-1) is a novel lncRNA that involved in cell apoptosis and proliferation of prostate cancer.
|
28571676 |
2017 |
|
Malignant neoplasm of prostate
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Prostate cancer-associated non-coding RNA transcript-1(PCAT-1), which is a newly discovered long non-coding RNA, is up-regulated in various cancers.
|
29378170 |
2018 |
|
Malignant neoplasm of prostate
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Prostate-cancer-associated ncRNA transcript 1 (PCAT-1), a newly discovered lncRNA, was implicated in the progression of multiple tumors.
|
30508953 |
2018 |
|
Malignant neoplasm of prostate
|
0.500 |
Biomarker
|
disease |
BEFREE |
Prostate cancer-associated transcript 1 (PCAT-1) is a novel lncRNA that promotes cell proliferation in prostate cancer.
|
25934337 |
2015 |
|
Malignant neoplasm of prostate
|
0.500 |
Biomarker
|
disease |
BEFREE |
PCAT1 promotes prostate cancer cell proliferation and tumor growth in vitro and in vivo.
|
27526323 |
2016 |
|
Malignant neoplasm of prostate
|
0.500 |
Biomarker
|
disease |
BEFREE |
PCAT1 may be involved in cell cycle and proliferation of prostate cancers by mediating the expression of <i>CENPF</i>, <i>ID1</i>, and <i>ID3</i>.</b>
|
31090454 |
2019 |
|
Malignant neoplasm of prostate
|
0.500 |
Biomarker
|
disease |
CTD_human |
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.
|
26752646 |
2016 |
|
Malignant neoplasm of prostate
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Evaluating genetic risk for prostate cancer among Japanese and Latinos.
|
22923026 |
2012 |
|
Malignant neoplasm of prostate
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, 4 genes, MSMB, NCOA4, PCAT1, and PPP1R14A, are associated with PrCa in a trans-ethnic meta-analysis (N = 9117).
|
31308362 |
2019 |
|
Malignant neoplasm of prostate
|
0.500 |
Biomarker
|
disease |
BEFREE |
Furthermore, because this human counterpart of AlkB exhibits a protective function against alkylation damage in mammalian cells, PCA-1 may also serve as a therapeutic target molecule for prostate cancer.
|
16033822 |
2005 |
|
Malignant neoplasm of prostate
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.
|
24753544 |
2014 |
|
Malignant neoplasm of prostate
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.
|
19767754 |
2009 |
|
Malignant neoplasm of prostate
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.
|
17401366 |
2007 |
|
Malignant neoplasm of prostate
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.
|
20676098 |
2010 |
|
Malignant neoplasm of prostate
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study identifies new prostate cancer susceptibility loci.
|
21743057 |
2011 |
|
Malignant neoplasm of prostate
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.
|
23023329 |
2012 |
|
Malignant neoplasm of prostate
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.
|
17401363 |
2007 |
|
Malignant neoplasm of prostate
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population.
|
23555315 |
2013 |
|
Malignant neoplasm of prostate
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
High expression of PCAT-1 is observed in different types of cancers, including prostate cancer, colorectal cancer, hepatocellular cancer and gastric cancer.
|
30906215 |
2019 |
|
Malignant neoplasm of prostate
|
0.500 |
Biomarker
|
disease |
BEFREE |
In conclusion, these findings suggested that PCAT-1 accelerated PC cell proliferation, migration, invasion and suppressed apoptosis by up-regulating FSCN1 mediated via miR-145-5p, hinting a potential therapeutic strategy for PC patients.
|
28922730 |
2017 |
|
Malignant neoplasm of prostate
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Multiple loci identified in a genome-wide association study of prostate cancer.
|
18264096 |
2008 |
|
Malignant neoplasm of prostate
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Multiple newly identified loci associated with prostate cancer susceptibility.
|
18264097 |
2008 |